Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT06585202 · COMPLETED
Trial details
- NCT number
- NCT06585202
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-19
- Primary completion
- 2025-03-13
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.